How the “full-stack” diabetes management company is trying to prevent people from needing its services later.
One Drop, the makers of a namesake mobile-integrated glucose monitoring device, today announced a new 12-month weight loss and diabetes prevention program called Revive. The program was awarded Pending Recognition by the Centers for Disease Control and Prevention (CDC).
Revive is based on the CDC’s PreventT2 curriculum, with a goal of helping users lose 5 to 7% of body weight in a year to prevent or delay onset of type 2 diabetes.
One Drop Vice President of Clinical Operations and Innovation Dr. Mark Heyman said in a statement that prediabetes was a “public health crisis” and that Revive is the “logical next step for One Drop’s ‘full-stack’ data-driven diabetes management solution.” According to the American Diabetes Association prediabetes—elevated blood A1c levels of between 5.7% and 6.4%—is prevalent in over 80 million American adults.
The program will be integrated with One Drop’s existing Experts program, allowing users to connect 24/7 with a “coach” who provides education and guidance. The statement says that the full course of Revive is expected to cost $200 annually per enrolled user, “making it one of the most cost-effective solutions with the highest ROI in market,” for patients, employers, health systems, and insurers.
At this year’s American Diabetes Association Scientific Sessions, a study was presented that showed the company’s One Drop Mobile app and Experts program capable of reducing users’ A1c by 1% in 3 months, with a greater yield for those with baseline A1c of 9% or above. The company hopes it can have similar success in preventing type 2 diabetes in the first place.
Citing his platform’s combination of behavioral science, professional health coaching, peer support, and connected devices, One Drop CEO and founder Jeff Dachis said in the statement that "With Revive, we can improve the lives of even more people and prevent disease before it starts."